157 related articles for article (PubMed ID: 28269951)
1. Literature-Based Discovery of Confounding in Observational Clinical Data.
Malec SA; Wei P; Xu H; Bernstam EV; Myneni S; Cohen T
AMIA Annu Symp Proc; 2016; 2016():1920-1929. PubMed ID: 28269951
[TBL] [Abstract][Full Text] [Related]
2. Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance.
Malec SA; Wei P; Bernstam EV; Boyce RD; Cohen T
J Biomed Inform; 2021 May; 117():103719. PubMed ID: 33716168
[TBL] [Abstract][Full Text] [Related]
3. Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records.
Lee S; Choi J; Kim HS; Kim GJ; Lee KH; Park CH; Han J; Yoon D; Park MY; Park RW; Kang HR; Kim JH
J Am Med Inform Assoc; 2017 Jul; 24(4):697-708. PubMed ID: 28087585
[TBL] [Abstract][Full Text] [Related]
4. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.
Coloma PM; Avillach P; Salvo F; Schuemie MJ; Ferrajolo C; Pariente A; Fourrier-Réglat A; Molokhia M; Patadia V; van der Lei J; Sturkenboom M; Trifirò G
Drug Saf; 2013 Jan; 36(1):13-23. PubMed ID: 23315292
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. 3D pharmacophoric similarity improves multi adverse drug event identification in pharmacovigilance.
Vilar S; Tatonetti NP; Hripcsak G
Sci Rep; 2015 Mar; 5():8809. PubMed ID: 25744369
[TBL] [Abstract][Full Text] [Related]
7. A method for controlling complex confounding effects in the detection of adverse drug reactions using electronic health records.
Li Y; Salmasian H; Vilar S; Chase H; Friedman C; Wei Y
J Am Med Inform Assoc; 2014; 21(2):308-14. PubMed ID: 23907285
[TBL] [Abstract][Full Text] [Related]
8. Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review.
Luo Y; Thompson WK; Herr TM; Zeng Z; Berendsen MA; Jonnalagadda SR; Carson MB; Starren J
Drug Saf; 2017 Nov; 40(11):1075-1089. PubMed ID: 28643174
[TBL] [Abstract][Full Text] [Related]
9. Identifying plausible adverse drug reactions using knowledge extracted from the literature.
Shang N; Xu H; Rindflesch TC; Cohen T
J Biomed Inform; 2014 Dec; 52():293-310. PubMed ID: 25046831
[TBL] [Abstract][Full Text] [Related]
10. Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug Reactions.
Backenroth D; Chase H; Friedman C; Wei Y
PLoS One; 2016; 11(10):e0164304. PubMed ID: 27716785
[TBL] [Abstract][Full Text] [Related]
11. Development of a Controlled Vocabulary-Based Adverse Drug Reaction Signal Dictionary for Multicenter Electronic Health Record-Based Pharmacovigilance.
Lee S; Han J; Park RW; Kim GJ; Rim JH; Cho J; Lee KH; Lee J; Kim S; Kim JH
Drug Saf; 2019 May; 42(5):657-670. PubMed ID: 30649749
[TBL] [Abstract][Full Text] [Related]
12. Classification-by-Analogy: Using Vector Representations of Implicit Relationships to Identify Plausibly Causal Drug/Side-effect Relationships.
Mower J; Subramanian D; Shang N; Cohen T
AMIA Annu Symp Proc; 2016; 2016():1940-1949. PubMed ID: 28269953
[TBL] [Abstract][Full Text] [Related]
13. Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review.
Davis SE; Zabotka L; Desai RJ; Wang SV; Maro JC; Coughlin K; Hernández-Muñoz JJ; Stojanovic D; Shah NH; Smith JC
Drug Saf; 2023 Aug; 46(8):725-742. PubMed ID: 37340238
[TBL] [Abstract][Full Text] [Related]
14. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.
Cederholm S; Hill G; Asiimwe A; Bate A; Bhayat F; Persson Brobert G; Bergvall T; Ansell D; Star K; Norén GN
Drug Saf; 2015 Jan; 38(1):87-100. PubMed ID: 25539877
[TBL] [Abstract][Full Text] [Related]
15. A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions.
Li Y; Ryan PB; Wei Y; Friedman C
Drug Saf; 2015 Oct; 38(10):895-908. PubMed ID: 26153397
[TBL] [Abstract][Full Text] [Related]
16. A Comparison Study of Algorithms to Detect Drug-Adverse Event Associations: Frequentist, Bayesian, and Machine-Learning Approaches.
Pham M; Cheng F; Ramachandran K
Drug Saf; 2019 Jun; 42(6):743-750. PubMed ID: 30762164
[TBL] [Abstract][Full Text] [Related]
17. Detection of pharmacovigilance-related adverse events using electronic health records and automated methods.
Haerian K; Varn D; Vaidya S; Ena L; Chase HS; Friedman C
Clin Pharmacol Ther; 2012 Aug; 92(2):228-34. PubMed ID: 22713699
[TBL] [Abstract][Full Text] [Related]
18. Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control.
Wood ME; Lapane KL; van Gelder MMHJ; Rai D; Nordeng HME
Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):140-147. PubMed ID: 29044735
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacovigilance in Germany : It is about time].
Douros A; Schaefer C; Kreutz R; Garbe E
Internist (Berl); 2016 Jun; 57(6):616-23. PubMed ID: 27224991
[TBL] [Abstract][Full Text] [Related]
20. Data mining methodology for response to hypertension symptomology-application to COVID-19-related pharmacovigilance.
Xu X; Kawakami J; Millagaha Gedara NI; Riviere JE; Meyer E; Wyckoff GJ; Jaberi-Douraki M
Elife; 2021 Nov; 10():. PubMed ID: 34812146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
